Skip to main content

Advertisement

Table 1 Subject characteristics, basal and postprandial FGF19 serum concentrations

From: Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Variables Control Overweight Obesity p-value
N (men/women) 16 (7/9) 14 (8/6) 12 (6/6) n.s.a
Age (years) 29.5 (24.0–53.0) 49.0 (38.8–57.3) 48.0 (37.0–57.3) 0.551b
BMI (kg/m2) 24.2 (21.8–26.6) 28.3 (26.3–29.2) 35.3 (32.7–39.0) <  0.001b
FGF19 (pg/ml)
 t = 0 h 178.5 (101.0–257.0)c 127.5 (70.0–161.3) 116.0 (51.0–134.3)c 0.01c
 t = 2 h 244.5 (161.5–377.5)c 163.0 (78.5–168.3)c 181.0 (85.3–393.0) 0.004c
 t = 4 h 332.5 (202.0–590.8) 207.0 (112.5–365.0) 220.0 (138.8–385.3) 0.445b
 t = 6 h 211.0 (165.3–296.3) 154.0 (124.0–254.0) 184.5 (110.5–274.3) 0.445b
  1. All data are given as median (interquartile range)
  2. aChi-square-test
  3. bKruskal-Wallis-test
  4. cMann-Whitney-U-test